- Home
- PTAC vs EVMN Comparison
PTAC vs EVMN Comparison
Compare PTAC & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
BUY
Current Price
$6.05
Company Overview
Basic Information| Metric | PTAC | EVMN |
|---|---|---|
| Founded | 2025 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.5M | 241.3M |
| IPO Year | 2026 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PTAC | EVMN |
|---|---|---|
| Price | $9.99 | $6.05 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $22.33 |
| AVG Volume (30 Days) | 31.9K | ★ 839.3K |
| Earning Date | N/A | 11-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.23 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 85.71 |
| 52 Week Low | $9.88 | $6.02 |
| 52 Week High | $10.02 | $33.20 |
Technical Indicators
Market Signals| Indicator | PTAC | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 53.10 | 18.89 |
| Support Level | N/A | N/A |
| Resistance Level | $10.02 | $13.35 |
| Average True Range (ATR) | 0.01 | 0.51 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 66.67 | 2.27 |
Price Performance
Historical Comparison PTAC
EVMN
About PTAC Patriot Acquisition Corp. Class A Ordinary Shares
Patriot Acquisition Corp is a blank check company.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.